Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004572653 | SCV003341852 | uncertain significance | Familial adenomatous polyposis 1 | 2022-04-08 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with APC-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 2799 of the APC protein (p.Ser2799Thr). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004946161 | SCV005462164 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-08-07 | criteria provided, single submitter | clinical testing | The p.S2799T variant (also known as c.8395T>A), located in coding exon 15 of the APC gene, results from a T to A substitution at nucleotide position 8395. The serine at codon 2799 is replaced by threonine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. Based on the available evidence, the clinical significance of this variant remains unclear. |